Acuta Capital Partners as of Sept. 30, 2025
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 28 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ocular Therapeutix (OCUL) | 14.1 | $14M | 1.2M | 11.69 | |
| Cidara Therapeutics Com New (CDTX) | 14.0 | $14M | 142k | 95.76 | |
| Tourmaline Bio (TRML) | 13.3 | $13M | 269k | 47.83 | |
| Aadi Bioscience (WHWK) | 6.7 | $6.5M | 3.4M | 1.90 | |
| Insmed Com Par $.01 (INSM) | 5.7 | $5.6M | 39k | 144.01 | |
| Bright Minds Biosciences Com New (DRUG) | 5.3 | $5.1M | 85k | 60.66 | |
| Argen Se - Sponsored Adr (ARGX) | 4.9 | $4.7M | 6.4k | 737.56 | |
| Amylyx Pharmaceuticals (AMLX) | 4.7 | $4.5M | 333k | 13.59 | |
| Terns Pharmaceuticals (TERN) | 3.9 | $3.8M | 503k | 7.51 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 3.4 | $3.3M | 25k | 131.80 | |
| Compass Therapeutics (CMPX) | 3.0 | $2.9M | 840k | 3.50 | |
| Praxis Precision Medicines I (PRAX) | 2.7 | $2.6M | 50k | 53.00 | |
| Surrozen Com New (SRZN) | 2.4 | $2.3M | 178k | 12.88 | |
| Ascendis Pha- Sponsored Adr (ASND) | 2.0 | $1.9M | 9.8k | 198.81 | |
| Krystal Biotech (KRYS) | 1.9 | $1.9M | 11k | 176.53 | |
| Oculis Holding Ordinary Shares (OCS) | 1.8 | $1.8M | 102k | 17.58 | |
| Taysha Gene Therapies Com Shs (TSHA) | 1.5 | $1.5M | 455k | 3.27 | |
| Cogent Biosciences (COGT) | 1.5 | $1.5M | 103k | 14.36 | |
| Zymeworks Del (ZYME) | 1.4 | $1.4M | 80k | 17.08 | |
| Verastem Com New (VSTM) | 1.3 | $1.3M | 143k | 8.83 | |
| Dianthus Therapeutics (DNTH) | 1.0 | $984k | 25k | 39.35 | |
| United Therapeutics Corporation (UTHR) | 1.0 | $963k | 2.3k | 419.21 | |
| Inhibrx Biosciences (INBX) | 0.6 | $552k | 16k | 33.68 | |
| Fulcrum Therapeutics (FULC) | 0.5 | $526k | 57k | 9.20 | |
| Lb Pharmaceuticals Com Shs | 0.5 | $474k | 30k | 15.79 | |
| Revolution Medicines (RVMD) | 0.4 | $393k | 8.4k | 46.70 | |
| Unicycive Therapeutics (UNCY) | 0.3 | $262k | 60k | 4.36 | |
| Nuvation Bio Inc -cw27 *w Exp 07/07/2027 (NUVB.WS) | 0.0 | $18k | 91k | 0.20 |
